Jennifer Chee, MD
Clinical Cardiac Electrophysiology · Melrose, MANPI 1598185654
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (36.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Abbott accounts for 62.6% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $16,790, 7.4 times the $2,259 reported in 2020.
Across 364 payments — averaging $148.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$34K
- Biosense Webster, Inc.$7K
- Medtronic$5K
- Biotronik Inc.$4K
- Boston Scientific$2K
- Medical Device Business Services, Inc.$2K
- plus $239 from 4 others
What the payments were for
- Consulting fees$11,78822%
- Speaking & faculty fees$3,1886%
- Grants$1,5783%
- Travel & lodging$19,93937%
- Food & beverage$17,13132%
- Education$5321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 244 | $33,894 |
| Biosense Webster, Inc. | 35 | $7,179 |
| Medtronic(2 entities) | 41 | $5,044 |
| Biotronik Inc. | 16 | $4,152 |
| Boston Scientific | 18 | $1,964 |
| Medical Device Business Services, Inc. | 6 | $1,682 |
| Atricure, Inc. | 1 | $163 |
| Philips North America LLC | 1 | $38 |
| Cordis US CORP. | 1 | $25 |
| Portola Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE$12,937
- ENSITE PRECISION$8,765
- AVEIR$3,987
- Carto 3$3,421
- Rivacor 7 DR-T$1,468
- Edora 8 DR-T$1,468
- Acticor 7 VR-T DX$1,321
- Micra$1,011
- Solia$838
- BioMonitor$838
- Sentus$483
- GALLANT$415
- QDOT MICRO Catheter$377
- WATCHMAN Access System$355
- GENERAL - THERAPIES$298
- FLEXABILITY$233
- COBALT DR MRI SURESCAN$183
- Ensite Cardiac Mapping System$179
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$163
- EnSite Precision Cardiac Mapping System$157
How this compares
$54,155 in reported general payments places this provider in the 75th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.
See all clinical cardiac electrophysiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $24,087 |
| Amiodarone Hcl | 14 | $726 |
| Metoprolol Succinate | 23 | $559 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Melrose
- Elad AnterBoston$3.9M
- Nitesh SoodFall River$668K
- Jagmeet SinghBoston$619K
- Andre DavilaBoston$379K
- Kevin FloydWorcester$278K
- Daniel KramerBoston$247K
- Gregory MichaudBoston$244K
- Matthew ReynoldsBurlington$217K
- Laurence EpsteinBoston$172K
- Leon PtaszekBoston$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.